Zhejiang Pharmaceutical Industry Corp., Ltd.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Zhejiang Pharmaceutical Industry Corp., Ltd. - overview
Established
1976
Location
Hangzhou, Zhejiang, China
Primary Industry
Pharmaceuticals
About
Founded in 1976 and headquartered in Hangzhou, China, Zhejiang Pharmaceutical Industry Corp. , Ltd. was originally established as a provincial pharmaceutical administration entity and later transitioned into a market-oriented pharmaceutical company. In 1999, the company was restructured with investment from Zhejiang Hisun Pharmaceutical Co.
, Ltd. and Intai Pharmaceutical, and in 2013 became a wholly owned subsidiary of Hisun Pharmaceutical. The company subsequently expanded its pharmaceutical distribution and logistics capabilities nationwide. In December 2025, Guangzhou Pharmaceuticals Co.
, Ltd. agreed to fully acquire the company for CNY 500. 50 million. The company provides pharmaceutical manufacturing, wholesale distribution, and logistics services, covering prescription drugs, OTC medicines, veterinary drugs, healthcare foods, pharmaceutical intermediates, medical devices and related supplies.
The company generates revenue primarily through B2B pharmaceutical distribution and wholesale sales. Following the acquisition agreement with Guangzhou Pharmaceuticals Co. , Ltd. , the company plans to integrate its distribution and logistics operations into a broader national pharmaceutical supply network and continue expanding coverage.
Primary Industry
Pharmaceuticals
Sub Industries
Retail, Pharmaceuticals
Website
www.zjyygy.com/
Company Stage
Add-on
Total Amount Raised
Subscriber access only
Zhejiang Pharmaceutical Industry Corp., Ltd. - financials
| Fiscal Year Ended | Dec 31, 2024 |
|---|---|
| Revenue (USD) | - |
| % Revenue Growth (YoY) | - |
| EBITDA (USD) | - |
| Operating Income (USD) | - |
| Operating Margin | - |
| % EBITDA Margin | - |
| NET Income (USD) | - |
| % Net Margin | - |
Zhejiang Pharmaceutical Industry Corp., Ltd. - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Add-on | Announced | Zhejiang Pharmaceutical Industry Corp., Ltd. | - |
Displaying 1 - 1 of 1
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.